Viscient Bio Inc
PrivateLast Round
Convertible Debt
Sep 15, 2021
Total Funding Raised
$1M
Company Overview
Viscient Bio Inc is a biotechnology company that develops novel therapies for liver diseases using proprietary 3D human tissue models.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viscient Bio Inc Comps
Public and private peers based on sector, stage, and business model.
Viscient Bio Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Sep 15, 2021 |
Key People
Founding team and executive leadership
Viscient Bio Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SternAegis Ventures | Convertible Debt |
| Thynk Capital | Convertible Debt |
| Harmonix Fund | Convertible Debt |
| Methuselah Foundation | Convertible Debt |
Viscient Bio Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Viscient Bio Inc's valuation, stock price, and market status.
